Patrick Ridgeway | Blogspot

Showing posts with the label Preventable Adverse Drug Reactions

Posts

About Me

Over the course of his career, Patrick Ridgeway has demonstrated success in the marketing and development of advanced medical technology. He currently leads as founding and managing partner of UTC Reference Laboratories, a diagnostic reference group active in drug metabolism, genetic wellness, genetic skin care, and advanced women's health. Owner of intellectual property for genetic testing with direct to consumer report capabilities, Patrick Ridgeway also works closely with hospitals to use testing to improve patient outcome and avoid adverse reactions.

Patrick Ridgeway comes to this role with an accomplished history in medical technology sales, having most recently served as regional manager for Endologix Inc. There, he distinguished himself as the driver of the greatest regional growth for the company in the 2011 fiscal year. He accepted this role following successful service as regional director at St. Jude Medical, where he earned President's Club honors for his work with hospital leaders to create centers of excellence in arterial fibrillation.

Mr. Ridgeway has also earned similar honors for his work with Medtronic, Boston Scientific, and Specialty Surgical Instrumentation. He holds a bachelor's degree in business from the University of Mississippi and promotes health on a personal level as well, being a supporter of organizations such as the American Heart Association and the Susan G. Komen foundation.

Patrick Ridgeway | Blogspot

Search This Blog

Posts

The Financial Burden of Preventable Adverse Drug Reactions